Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions

Oncogene

Volumn 14, Issue 3, 1997, Pages 339-347

  Kerangueven, Fabienne ^a   Eisinger, François ^a   Noguchi, Tetsuro ^a   Allione, Florence ^a   Wargniez, Véronique ^a   Eng, Charis ^b   Padberg, Georges ^c   Theillet, Charles ^d   Jacquemier, Jocelyne ^a   Longy, Michel ^e   Sobol, Hagay ^a   Birnbaum, Daniel ^a,f  

^a INSTITUT PAOLI CALMETTES   (France)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^e INSTITUT BERGONIÉ   (France)

^f INSERM   (France)

Author keywords

Ataxia telangiectasia; BRCA1; Breast cancer; Chromosome 10; Chromosome 11; Chromosome 17

Indexed keywords

DNA MARKER; MICROSATELLITE DNA;

ARTICLE; ATAXIA TELANGIECTASIA; BREAST CARCINOMA; CANCER GENETICS; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME 17; COWDEN SYNDROME; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 8044228391     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200818     Document Type: Article

References (54)

1. Agresti A, Mehta C and Patel N. (1990). Exact inference for contingency tables with ordered categories. J. Am. Statist. Assoc., 85, 543-558.
2. Baffa R, Negrini M, Mandes B, Rugge M, Ranzani G, Hirohashi S and Croce C. (1996). Loss of heterzygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res., 56, 268-272.
3. Baffa R, Negrini M, Schichman S, Huebner K and Croce C. (1995). Involvement of the ALL-1 gene in a solid tumor. Proc. Natl. Acad. Sci. USA, 92, 4922-4926.
4. Bethwaite P, Koreth J, Herrington C and McGee JO'D. (1995). Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma. Br. J. Cancer, 71, 814-818.
5. Bieche I and Lidereau R. (1995). Genetic alterations in breast cancer. Genes Chromosom. Cancer, 14, 227-251.
6. Carter S, Negrini M, Baffa R, Gillum D, Rosenberg A, Schwartz G and Croce C. (1994). Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res., 54, 6270-6274.
7. Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse C and Stratton M. (1995). Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br. J. Cancer, 72, 1241-1244.
8. Cropp C, Champeme MH, Lidereau R and Callahan R. (1993). Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res., 53, 5617-5619.
9. Davis M, Hitchcock A, Foulkes W and Campbell I. (1996). Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res., 56, 741-744.
10. Devilee P and Cornelisse C. (1994). Somatic genetic changes in human breast cancer. Biochem. Biophys. Acta, 1198, 113-130.
11. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. (1996). A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature, 380, 152-154.
12. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jacqueimer J, Birnbaum D and Sobol H. (1996). Germ line mutation at BRCAI affects the histoprognostic grade in hereditary breast cancer. Cancer Res., 56, 471-474.
13. Ferti-Passantonopoulou A, Panani A and Raptis S. (1991). Preferential involvement of 11q23-24 and 11p15 in breast cancer. Cancer Genet. Cytogenet., 51, 183-188.
14. Foulkes W, Campbell I, Stamp G and Trowsdale J. (1993). Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br. J. Cancer, 67, 268-273.
15. Gabra H, Watson V, Taylor K, Mackay J, Leonard R, Steel M, Porteous D and Smyth J. (1996). Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res., 56, 950-954.
16. Gaudray P, Szepetowski P, Escot C, Birnbaum D and Theillet C. (1992). DNA amplification at 11q13 in human cancer: from complexity to perplexity. Mutat. Res., 276, 317-328.
17. Gray I, Phillips S, Lee S, Neoptolemos J, Weissenbach J and Spurr NK. (1995). Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res., 55, 4800-4803.
18. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernadi G, Lathrop M and Weissenbach J. (1994). The 1992-94 Généthon human genetic linkage map. Nature Genet., 7, 246-339.
19. Hainsworth P, Raphael K, Stillwell R, Bennett R and Garson M. (1991). Cytogenetic features of twenty-six primary breast cancers. Cancer Genet. Cytogenet., 52, 205-218.
20. Hampton G, Mannermaa A, Winquist R, Alavaikko M, Blanco G, Taskinen P, Kiviniemi H, Newsham I, Cavanee W and Evans G. (1994a). Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res., 54, 4586-4589.
21. Hampton G, Penny L, Baergen R, Larson A, Brewer C, Liao S, Busby-Earle R, Williams A, Steel C, Bird C, Stanbridge E and Evans G. (1994b). Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc. Natl. Acad. Sci. USA, 91, 6953-6957.
22. Herbst R, Larson A, Weiss J, Cavenee W, Hampton G and Arden K. (1995). A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res., 55, 2494-2496.
23. Hollander M and Wolfe D. (1973). The one way out. In: Non parametric statistical methods. M Hollander and D Wolfe (eds). John Wiley and sons, NY pp 115-132.
24. Hui A, Lo KW, Leung SF, Choi PHK, Fong Y, Lee JCK and Huang DP. (1996). Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Oncogene, 56, 3225-3229.
25. Iizuka M, Sugiyama Y, Shiraishi M, Jones C and Sekiya T. (1995). Allelic losses in human chromosome 11 in lung cancers. Genes Chrom. Cancer, 13, 40-46.
26. Ittman M. (1996). Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res., 56, 2143-2147.
27. Keldysh P, Dragani T, Fleischman E, Konstantinova L, Perevoschikov A, Pierotti M, Della Porta G and Kopnin B. (1993). 11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chrom. Cancer, 6, 45-50.
28. Kerangueven F, Allione F, Noguchi T, Adelaide J, Sobol H, Jacquemier J and Birnbaum D. (1995a). Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chrom. Cancer, 13, 271-274.
29. Kerangueven F, Eisinger F, Allione F, Wargniez V, Parc P, Jacquemier J, Noguchi T, Sobol H and Birnbaum D. (1996). Cumulative regional allelotyping of human breast carcinomas: application to chromosomes 1 to 5. Int. J. Oncol., 8, 1155-1163.
30. Kerangueven F, Essioux L, Dib A, Noguchi T, Allione F, Geneix J, Longy M, Lidereau R, Eisinger F, Pebusque M-J, Jacquemeir J, Bonaiti-Pellie C, Sobol H and Birnbaum D. (1995b). Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene, 10, 1023-1026.
31. Kerangueven F, Noguchi T, Adelaide J, Jacquemier J, Sobol H and Birnbaum D. (1995c). Allelic loss at markers of chromosomal band 7q31 is not a frequent event in human breast cancer. Oncology Rep., 2, 89-90.
32. Kirchweger R, Zeillinger R, Schneeberger C, Speiser P, Louason G and Theillet C. (1994). Paterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int. J. Cancer. 56, 193-199.
33. Koreth J, Bethwaite P and McGee JO'D. (1995). Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. J. Pathol., 176, 11-18.
34. Lindblom A, Sandelin K, Iselius L, Dumanski J, White I, Nordenskjold M and Larsson C. (1994). Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. Am. J. Human Genet., 54, 871-876.
35. Moschonas N, Spurr N and Mao J. (1996). Report of the first international workshop on human chromosome 10 mapping 1995. Cytogenet. Cell Genet., 72, 99-112.
36. Nagai M, Medeiros A, Brentani M, Brentani R, Marques L, Mazoyer S and Mulligan L. (1995). Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology, 52, 448-453.
37. Negrini M, Rasio D, Hampton G, Sabbioni S, Rattan S, Carter S, Rosenberg A, Schwartz G, Shiloh Y Cavenee W and Croce C. (1995). Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res., 55, 3003-3007.
38. Nelen M, Padberg G, Peeters E, Lin A, Van der Helm B, Frants R, Coulon V, Goldstein A, Van Reen M, Easton D, Eeles R, Hodgson S, Mulvihill J, Murday V, Tucker M, Mariman E, Starink T, Ponder B, Ropers H, Kremer H, Longy M and Eng C. (1996). Localisation of the gene for Cowden disease to chromosome log 22-23. Nature Genet., 13, 114-116.
39. Phillips K, Welch D, Miele M, Lee JH, Wei L and Weissman B. (1996). Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res., 56, 1222-1227.
40. Rasio D, Negrini M, Manenti G, Dragani T and Croce C. (1995). Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res., 55, 3988-3991.
41. Rowley J. (1993). Rearrangements involving chromosome band 11q23 in acute leukaemia. Semin. Cancer Biol., 4, 377-385.
42. Sanchez Y, Lovell M, Marin M, Wong P, Wolf-Ledbetter E, McDonnell T and McNeill Killary A. (1996). Tumor suppression and apoptosis of human prostate carcinomas mediated by a genetic locus within human chromosome 10pter-q11. Cancer Res., 93, 2551-2556.
43. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle D, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali S, Simmons A, Clines G, Sartiel A, Gatti R, Chessa L, Sanal O, Lavin M, Jaspers N, Taylor M, Arlett C, Miki T, Weissman S, Lovett M, Collins F and Shiloh Y. (1995). A single ataxia telangectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753.
44. Schultz D, Vanderveer L, Berman D, Hamilton T, Wong A and Godwin A. (1996). Identification of two candidate tumor suppressor genes on chromsome 17q13.3. Cancer Res., 56, 1997-2002.
45. Shaw M and Knowles M. (1995). Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chrom. Cancer, 13, 1-8.
46. Sobol H, Birnbaum D and Eisinger F. (1994). Evidence for a third breast-cancer susceptibility gene. Lancet, 344, 1151-1152.
47. Starink TM, Van Der Veen JP, Arwert F, De Waal LP, De Lange GG, Gille JJ and Eriksson AW. (1986). The Cowden syndrome: a clinical and genetic study in 21 patients. Clin. Genet., 29, 222-233.
48. Stratton M and Wooster R. (1996). Hereditary predisposition to breast cancer. Current Op. Genet. Develop., 6, 93-97.
49. Swift M, Reitnauer P, Morrell D and Chase C. (1987). Breast and other cancers in families with ataxia-telangiectasia. New Engl. J. Med., 316, 1289-1294.
50. Theillet C, Le Roy X, deLapeyrière O, Grosgeorges J, Adnane J, Raynaud S, Simony-Lafontaine J, Goldfarb M, Escot C, Birnbaum D and Gaudray P. (1989). Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene, 4, 915-922.
51. Tomlinson I, Gammack A, Stickland J, Mann G, Mackie R, Kefford R and McGee JO'D. (1993). Loss of heterozygosity in malignant melanoma at loci on chromosomes 11 and 17 implicated in the pathogenesis of other cancers. Genes Chrom. Cancer, 7, 169-172.
52. Van Heyningen V and Little PFR. (1995). Report of the fourth international workshop on human chromsome 11 mapping 1994. Cytogenet. Cell Genet., 69, 128-158.
53. Winqvist R, Hampton G, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen P, Evans G, Wright F, Newsham I and Cavenee W. (1995). Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res., 55, 2660-2664.
54. Zhuang Z, Merino M, Chuaqui R, Liotta L and Emmert-Buck M. (1995). Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res., 55, 467-471.